Trial Profile
COPE: Cannabinoids to Obviate Pain Experiment After Knee Replacement
Status:
Not yet recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 04 May 2022
Price :
$35
*
At a glance
- Drugs Cannabidiol (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Acronyms COPE
- 18 Sep 2019 Planned End Date changed from 1 Dec 2021 to 1 May 2022.
- 18 Sep 2019 Planned primary completion date changed from 1 Dec 2020 to 15 May 2021.
- 18 Sep 2019 Planned initiation date changed from 1 Aug 2019 to 1 May 2020.